Market Cap 40.59M
Revenue (ttm) 7.57M
Net Income (ttm) -76.58M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,011.62%
Debt to Equity Ratio -4.45
Volume 447,000
Avg Vol 379,786
Day's Range N/A - N/A
Shares Out 91.78M
Stochastic %K 13%
Beta 1.44
Analysts Sell
Price Target $3.33

Latest News on VRCA

Verrica Pharmaceuticals Appoints Noah L. Rosenberg, M.D.

Mar 26, 2025, 7:00 AM EDT - 7 days ago

Verrica Pharmaceuticals Appoints Noah L. Rosenberg, M.D.


Verrica Announces Pricing of $42.0 Million Public Offering

Nov 21, 2024, 7:30 AM EST - 4 months ago

Verrica Announces Pricing of $42.0 Million Public Offering


Verrica Announces Proposed Public Offering

Nov 20, 2024, 4:05 PM EST - 4 months ago

Verrica Announces Proposed Public Offering